Published in
Elsevier, Journal of Hepatology, 1(66), p. S25
DOI: 10.1016/s0168-8278(17)30312-4
Links
Tools
Improved bone and renal safety of switching from tenofovir disoproxil fumarate to tenofovir alafenamide: preliminary results from 2 phase 3 studies in HBeAg-positive and HBeAg-negative patients with chronic hepatitis B
Journal article published in 2017 by
H. L. Chan,
S. Fung,
W. K. Seto,
E. Gane,
J. F. Flaherty,
V. Suri,
L. Lin,
A. Gaggar,
G. M. Subramanian,
W. L. Chuang,
K. Agarwal 
,
H. L. Janssen,
M. Buti
,
H. L. Janssen,
M. Buti
This paper was not found in any repository, but could be made available legally by the author.
Full text: Unavailable
Postprint:
archiving forbidden
Published version:
archiving forbidden
Data provided by 